Observational studyBMC ophthalmology2025
Refractive outcome and visual quality of Ray-Tracing Guided LASIK: a prospective study.
Observational study in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Initial Visual and Refractive Outcomes of Ray-Tracing-Guided LASIK (Wavelight Plus) Versus KLEx (SMILE Pro).Ophthalmology and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the safety and effectiveness of Ray-Tracing Guided LASIK surgery and to compare the refractive outcomes and visual quality between patients with spherical equivalent (SEQ) differences of ≤ 0.75D and > 0.75D, as measured by the InnovEyes sightmap and subjective refraction.
designProspective, observational cohort study. SUBJECTS: Forty-six patients (89 eyes) undergoing Ray-Tracing Guided LASIK with preoperative SEQ differences between sightmap and subjective refraction of either ≤ 0.75D or > 0.75D.
methodsPatients underwent preoperative examinations using InnovEyes sightmap diagnostic equipment to detect and measure biological parameters. A ray tracing-based algorithm was used to determine ablation contours, with direct application of ablation data for SEQ differences ≤ 0.75D and parameter adjustment for differences > 0.75D. Outcomes included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction spherical equivalent (MRSE), and total higher-order aberration (HOAs), measured preoperatively and six months postoperatively.
resultsSix months post-surgery, 100% of eyes in both groups achieved a postoperative UDVA of at least 20/25, with 76% of the ≤ 0.75D group and 81% of > 0.75D reaching 20/16. Additionally, 33% and 16% reached 20/12.5 in these groups, respectively. Postoperative CDVA was CDVA was equal to or better than preoperative levels in 98% of the ≤ 0.75D group and 95% of the > 0.75D group (P < 0.05). No significant overcorrection or undercorrection was observed. There were significant differences in vertical coma between preoperative and postoperative values in both groups (all P < 0.05), while there was no significant difference in other higher-order aberrations (P > 0.05).
conclusionRay-Tracing Guided-LASIK surgery is safe and effective. Compared with the preoperative BCVA, it can achieve better postoperative UDVA and effectively avoid the introduction of HOAs. In addition, for cases in which the MRSE difference between the two preoperative examination methods is ≥ 0.75, surgical design parameters adjustment can achieve ideal postoperative results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.